Compare Abeona Therapeutics Inc (ABEO) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Peloton Interactive Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Peloton Interactive Inc trades at $5.63 (market cap $2.46B). The key difference: Peloton Interactive Inc is far larger — about 5.8× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Peloton Interactive Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | PTON | |
|---|---|---|
Market Cap | $421.19M | $2.46B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.45 | $9.00 |
52-Week Low | $4.17 | $3.71 |
Enterprise Value | $276.10M | $2.96B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Peloton Interactive (PTON) trades at $5.51, down 2.99% on the day, reflecting ongoing investor caution despite achieving its first annual net profit in fiscal 2026. The stock shows a bearish technical trend with key support at $5, while fundamentals reveal a mixed picture: revenue declined to $2.49B in 2025 but net losses narrowed significantly, with a positive net income margin of 2.58% projected for 2026. Recent news highlights profitability milestones but also subscriber declines and a conservative 2027 outlook.
The outlook remains cautious; profitability improvements and cost control are positive, but persistent revenue erosion and high debt levels pose risks. Analyst sentiment is divided with a 50% buy rating, yet the stock's proximity to support levels suggests potential for stability if execution continues. Key risks include subscriber retention and competitive pressures in the fitness market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
